Literature DB >> 2988927

Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.

H Seifert, M Perrin, J Rivier, W Vale.   

Abstract

Specific high affinity binding sites for growth hormone releasing factor (GRF) were described in rat anterior pituitary homogenates with use of the analog [His1-mono-125I-Tyr10,Nle27]-hGRF(1-32)-NH2 as radioligand. Computerized analysis of competition experiments indicated one class of specific high affinity binding sites with a dissociation constant of 0.19 nM. The relative binding affinities of rGRF, hGRF(1-40) and various analogs correlated well with their in vitro biological potencies. Further, the number binding sites was drastically decreased after adrenalectomy; chronic dexamethasone treatment of these animals restored GRF binding capacity to control without changing binding affinity. These results may in part explain the enhanced responsiveness of the somatotroph after dexamethasone treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988927     DOI: 10.1210/endo-117-1-424

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.

Authors:  M B Lopes; B D Gaylinn; M O Thorner; M H Stoler
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 2.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

3.  Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization.

Authors:  H Oka; T Kameya; Y Sato; H Naritaka; N Kawano
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

Review 4.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity.

Authors:  A L Barkan; R DeMott-Friberg; M H Samuels
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

Review 6.  Glucocorticoids and the regulation of growth hormone secretion.

Authors:  Gherardo Mazziotti; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2013-02-05       Impact factor: 43.330

7.  Dexamethasone Stimulation Test in the Diagnostic Work-Up of Growth Hormone Deficiency in Childhood: Clinical Value and Comparison With Insulin-Induced Hypoglycemia.

Authors:  Alessandro Cattoni; Silvia Molinari; Francesco Medici; Paola De Lorenzo; Maria Grazia Valsecchi; Nicoletta Masera; Marta Adavastro; Andrea Biondi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-09       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.